For a strong Swiss medtech industry
Swiss Medtech was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative capacity, and to strengthen the domestic market.
Whether it be syringes, implants, wheelchairs, or MRIs - medical technology supplies people, doctors, and hospitals with vital products and applications. The domestic medtech industry generates annual sales of 15.8 billion and exports of 11.3 billion Swiss francs. It contributes 2.3% of the GDP. Swiss Medtech supports the Swiss medtech industry's continuing contribution to health care and the economy, as well as its ability to remain competitive internationally.
The Association represents the interests of the industry and serves 1,400 companies and 58,500 employees. It is committed to rapid patient access to innovation and high-quality standards. Swiss Medtech also initiates specialised training programmes, challenges rising levels of regulation, and pushes for free trade and fair tariffs. Together with its specialist groups and partners, the Association is committed to favourable conditions and to an attractive setting for research and other professional activities within Switzerland.